Dec 22, 2020Microvascular Therapeutics enters licensing agreement with UNC Chapel Hill and Columbia UniversityMicrovascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia...
Aug 1, 2020Microvascular Therapeutics receives NIH SBIR Phase I funds for its Alzheimer programTucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...
Jul 21, 2020Microvascular Therapeutics receives NIH SBIR Phase I funds for its program to treat heart attackTucson, Arizona, July 22nd, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...
Jul 9, 2018Microvascular Therapeutics Licenses Patent from Triangle Biotechnology Inc.Microvascular Therapeutics (MVT), LLC, a privately-held Tucson-based biotechnology company, has licensed a patent from Triangle...
Mar 29, 2018MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of HealthMicrovascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the...
Oct 31, 2017Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using SameREAD PATENT >